DISINFORMATION CASE DETAILS
- Outlet: iz.ru ( archive, original ) , Kommersant ( archive, original ) , ukraina.ru ( archive, original ) , rg.ru ( archive, original ) , tass.ru ( archive, original ) , argumenti.ru ( archive, original ) , vesti.ru ( archive, original ) , Rubaltic.ru ( archive, original ) , tsargrad.tv ( archive, original ) , russian.rt.com ( archive, original ) , tvzvezda.ru ( archive, original ) , ren.tv ( archive, original ) , sputniknews.com ( archive, original ) , mundo.sputniknews.com ( archive, original ) , br.sputniknews.com ( archive, original ) , rs.sputniknews.com ( archive, original ) , 3yonnews.com ( archive, original ) , akhbarak.net ( archive, original ) , aniraq.com ( archive, original ) , arabic.rt.com ( archive, original ) , Arabnews 24 ( archive, original ) , iq.shafaqna.com ( archive, original ) , tvzvezda.ru ( archive, original )
- Date of publication: December 08, 2020
- Countries / regions discussed: Ukraine, Russia
DISINFO: Ukrainian lab to produce Sputnik V vaccine
SUMMARY
The Russian Direct Investment Fund (RDIF) and the Gamaleya Centre are poised to manufacture the Sputnik V vaccine in Ukraine.
The Ukrainian pharmaceutical company Biolik has already arranged for the production of the vaccine.
RESPONSE
The story advances a recurring pro-Kremlin disinformation narrative flaunting the supposed superiority of the Russian-made coronavirus vaccine.
The claim was promptly debunked by the laboratory itself. On the day of RDIF's announcement, Biolik management issued a statement saying that the company "signed no contracts, received no technology transfers concerning the production of the Sputnik V vaccine," stressing that it conducts manufacturing operations "in accordance with Ukrainian laws currently in force" and "only in case of its [drug's] registration by the state."
According to Ukrainian Healthcare Minister Maksym Stepanov, the Ukrainian government is not planning to acquire the Russian vaccine, "given that the latter has not yet gone through the third stage of clinical trials."